Skip to contentO
Opus Genetics, Inc.
O
IRDOpus Genetics, Inc. Q1 2014 · 10-Q
Revenue$0.00$0.00— vs Q1 2013 Net Income-$14.60M-$14.60MN/M vs Q1 2013 EPS Diluted-$0.09-$0.09N/M vs Q1 2013 Operating Income-$2,766,094N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 14, 2014 · 44 d after period end